MORE►
Janus Henderson Investors
Left: Paul Wagner, chairman and CEO of Forte Biosciences; Right: Christopher Roenfeldt, COO at Forte Biosciences [Photos: Forte/LinkedIn]
Dallas’ Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors
by Lance Murray | Nov 21, 2024
Headquartered at Dallas' Pegasus Park, Forte Biosciences is developing a proprietary molecule with potentially broad autoimmune and autoimmune-related applications.
